Precision of health-related quality-of-life data compared with other clinical measures

Mayo Clinic Proceedings

Volumn 82, Issue 10, 2007, Pages 1244-1254

  Hahn, Elizabeth A ^a,i   Cella, David ^b,c   Chassany, Olivier ^d   Fairclough, Diane L ^e   Wong, Gilbert Y ^f,h   Hays, Ron D ^g  

^a Institute for Healthcare Studies ^*  (United States)

^b Institute for Healthcare Studies   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d SAINT LOUIS HOSPITAL   (France)

^e UNIVERSITY OF COLORADO   (United States)

^f MAYO CLINIC   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h Anesiva Inc   (United States)

ⁱ EVANSTON NORTHWESTERN HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ANALYTICAL ERROR; ASTHMA; CLINICAL DECISION MAKING; DATA ANALYSIS; DOCTOR PATIENT RELATION; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT SATISFACTION; QUALITY OF LIFE; RELIABILITY; REVIEW; RHEUMATOID ARTHRITIS; SELF REPORT; TREATMENT PLANNING;

EID: 34848901113     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/82.10.1244     Document Type: Article

References (122)

1. Frost MH, Bonomi AE, Cappelleri JC, Schünemann HJ, Moynihan TJ, Aaronson NK, Clinical Significance Consensus Meeting Group. Applying quality-of-life data formally and systematically into clinical practice. Mayo Clin Proc. 2007; 82(10):1214-1228.
2. German PS, Shapiro SH, Skinner EA, et al. Detection and management of mental health problems of older patients by primary care providers. JAMA. 1987;257(4):489-493.
3. Goldsmith G, Brodwick M. Assessing the functional status of older patients with chronic illness. Fam Med. 1989;21(1):38-41.
4. Linn LS, Yager J. The effect of screening, sensitization, and feedback on notation of depression. J Med Ed. 1980;55(11):942-949.
5. Magruder-Habib K, Zung WW, Feussner JR. Improving physicians' recognition and treatment of depression in general medical care: results from a randomized clinical trial. Med Care. 1990;28(3):239-250.
6. Mazonson PD, Mathias SD, Fifer SK, Buesching DP, Malek P, Patrick DL. The mental health patient profile: does it change primary care physicians' practice patterns? J Am Board Fam Pract. 1996;9(5):336-345.
7. McLachlan SA, Allenby A, Matthews J, et al. Randomized trial of coordinated psychosocial interventions based on patient self-assessments versus standard care to improve the psychosocial functioning of patients with cancer. J Clin Oncol. 2001;19(21):4117-4125.
8. Moore AA, Siu A, Partridge JM, Hays RD, Adams J. A randomized trial of office-based screening for common problems in older persons. Am J Med. 1997;102(4):371-378.
9. Rand EH, Badger LW, Coggins DR. Toward a resolution of contradictions: utility of feedback from the GHQ. Gen Hosp Psychiatry. 1988; 10(3):189-196.
10. Rubenstein LV, McCoy JM, Cope DW, et al. Improving patient quality of life with feedback to physicians about functional status. J Gen Intern Med. 1995;10(11):607-614.
11. Zung WW, Magill M, Moore JT, George DT. Recognition and treatment of depression in a family medicine practice. J Clin Psychiatry. 1983; 44(1):3-6.
12. Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial [published correction appears in JAMA 2003; 289(13):987]. JAMA. 2002;288(23):3027-3034.
13. Wright EP, Selby PJ, Crawford M, et al. Feasibility and compliance of automated measurement of quality of life in oncology practice. J Clin Oncol. 2003;21(2):374-382.
14. Reifler DR, Kessler HS, Bernhard EJ, Leon AC, Martin GJ. Impact of screening for mental health concerns on health service utilization and functional status in primary care patients. Arch Intern Med. 1996;156(22):2593-2599.
15. Wasson J, Keller A, Rubenstein L, Hays R, Nelson E, Johnson D. Benefits and obstacles of health status assessment in ambulatory settings: the clinician's point of view: the Dartmouth Primary Care COOP Project. Med Care. 1992;30(5, suppl):MS42-MS49.
16. Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK. Role of health-related quality of life in palliative chemotherapy treatment decisions. J Clin Oncol. 2002;20(4):1056-1062.
17. Brody DS, Lerman C, Wolfson HG, Caputo GC. Improvement in physicians counseling of patients with mental health problems. Arch Intern Med. 1990;150(5):993-998.
18. Greenhalgh J, Meadows K. The effectiveness of the use of patient-based measures of health in routine practice in improving the process and outcomes of patient care: a literature review. J Eval Clin Pract. 1999;5(4):401-416.
19. Espallargues M, Valderas JM, Alonso J. Provision of feedback on perceived health status to health care professionals: a systematic review of its impact. Med Care. 2000;38(2):175-186.
20. Velikova G, Booth L, Smith AB, et al. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol. 2004;22(4):714-724.
21. Wasson JH, Stukel TA, Weiss JE, Hays RD, Jette AM, Nelson EC. A randomized trial of the use of patient-self assessment data to improve community practices. Eff Clin Pract. 1999;2(1):1-10.
22. Albrecht G. Using subjective health assessments in practice and policy-making. Health Care Anal. 1996;4(4):284-292.
23. Carlson LE, Speca M, Hagen N, et al. Computerized quality-of-life screening in a cancer pain clinic. J Palliat Care. 2001 Spring;17(1):46-52.
24. Kazis LE, Callahan LF, Meenan RF, Pincus T. Health status reports in the care of patients with rheumatoid arthritis. J Clin Epidemiol. 1990;43(11):1243-1253.
25. Keir J, Engle J, Schlesinger-Raab A, Sauer H, Holzel D. Communication, quality of life, and age: results of a 5-year prospective study in breast cancer patients [published correction appears in Ann Oncol. 2003;14(6):967]. Ann Oncol. 2003;14(3):421-427.
26. Lansky D, Butler JB, Waller FT. Using health status measures in the hospital setting: from acute care to outcomes management. Med Care. 1992;30(5, suppl):MS57-MS73.
27. Lohr KN. Applications of health status assessment measures in clinical practice: overview of the third conference on advances in health status assessment. Med Care. 1992;30(5, suppl):MS1-MS14.
28. McHorney CA. Health status assessment methods for adults: past accomplishments and future challenges. Ann Rev Public Health. 1999;20:309-335.
29. Till JE. Measuring quality of life: apparent benefits, potential concerns. Can J Oncol. 1994;4(1):243-248.
30. Jacobsen PB, Davis K, Cella D. Assessing quality of life in research and clinical practice. Oncology (Williston Park). 2002;16(9, suppl 10):133-139.
31. Davis KM, Cella D. Assessing quality of life in oncology clinical practice: a review of barriers and critical success factors. J Clin Outcomes Manage. 2002;9(6):327-332.
32. Greenfield S, Nelson EC. Recent developments and future issues in the use of health status assessment measures in clinical settings. Med Care. 1992; 30(5, suppl):MS23-MS41.
33. Liang MH. Longitudinal construct validity: establishment of clinical meaning in patient evaluative instruments. Med Care. 2000;38(9, suppl):II84-II90.
34. Guyatt GH, Ferrans CE, Halyard MY, et al, Clinical Significance Consensus Meeting Group. An exploration of the value of health-related quality-of-life information from clinical research and into clinical practice. Mayo Clin Proc. 2007;82(10):1229-1239.
35. Apolone G. Clinical and outcome research in oncology: the need for integration. Health Qual Life Outcomes. 2003;1:1-6.
36. Cella DF, Bonomi AE. Measuring quality of life: 1995 update. Oncology (Williston Park). 1995;9(11, suppl):47-60.
37. Tranmer JE, Heyland D, Dudgeon D, Groll D, Squires-Graham M, Couslon K. Measuring the symptom experience of seriously ill cancer and non-cancer hospitalized patients near the end of life with the memorial symptom assessment scale. J Pain Symptom Manage. 2003;25(5):420-429.
38. Cordoba CS, Fobair P, Callan DB. Common issues facing adults with cancer. In: Steams NM, Lauria MM, Hermann JF, Fogelberg PR, eds. Oncology Social Work: A Clinician's Guide. Atlanta, GA: American Cancer Society; 1993:43-77.
39. Skeel RT. Quality of life dimensions that are most important to cancer patients. Oncology (Williston Park). 1993;7(12):55-61.
40. Loescher LJ, Welch-McCaffrey D, Leigh SA, Hoffman B, Meyerson FL Jr. Sirviving adult cancers: part 1: physiologic effects. Ann Intern Med. 1989;111(6):411-432.
41. Welch-McCaffrey D, Hoffman B, Leigh SA, Loescher LJ, Meyskens FL Jr. Surviving adult cancers: part 2: psychosocial implications. Ann Intern Med. 1989;111(6):517-524.
42. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA. 1995; 273(1):59-65.
43. Patrick D. Concept of health-related quality of life and of patient-reported outcomes. In: Chassany O, Caulin C, eds. Health-Related Quality of Life and Patient-Reported Outcomes: Scientific and Useful Outcome Criteria. Paris, France: Springer-Verlag; 2003:23-34.
44. Fleiss JL. Design and Analysis of Clinical Experiments. New York, NY: John Wiley & Sons; 1999.
45. Lord FM, Novick MR. Statistical Theories of Mental Test Scores. Reading, MA: Addison-Wesley; 1968.
46. Nunnally JC, Bernstein IH. Psychometric Theory. 3rd ed. New York, NY: McGraw-Hill; 1994.
47. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20(3):37-46.
48. Spitzer RL, Cohen J, Fleiss JL, Endicott J. Quantification of agreement in psychiatric diagnosis: a new approach. Arch Gen Psychiatry. 1967;17(1):83-87.
49. Cohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull. 1968;70:213-220.
50. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York, NY: Wiley; 1981.
51. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-174.
52. Ebel RL. Estimation of the reliability of ratings. Psychometrika. 1951; 16:407-424.
53. Haggard EA. Intraclass Correlation and the Analysis of Variance. New York, NY: Dryden Press; 1958.
54. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86(2):420-428.
55. Fleiss JL, Cohen J. The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educ Psychol Measurement. 1973;33:613-619.
56. Müller R, Büttner P. A critical discussion of intraclass correlation coefficients. Stat Med. 1994;13(23-24):2465-2476.
57. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use. New York, NY: Oxford University Press; 1995.
58. Altman DG, Bland JM. Measurement in medicine: the analysis of method comparison studies. Statistician. 1983;32:307-317.
59. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurements. Lancet. 1986;1(8476):307-310.
60. Bland JM, Altman DG. A note on the use of the intraclass correlation coefficient in the evaluation of agreement between two methods of measurement. Comput Biol Med. 1990;20(5):337-340.
61. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297-334.
62. Wyrwich KW, Neinaber NA, Tierney WM, Wolinsky FD. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care. 1999;37(5):469-478.
63. Wyrwich KW, Tierney WM, Wolinsky FD. Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol. 1999;52(9):861-873.
64. Cella D, Bullinger M, Scott C, Barofsky I, Clinical Significance Consensus Meeting Group. Group vs individual approaches to understanding the clinical significance of differences or changes in quality of life. Mayo Clin Proc. 2002;77(4):384-392.
65. Cella D, Chang CH. A discussion of item response theory and its applications in health status assessment. Med Care. 2000;38(9 suppl):II66-II72.
66. Chassany O. De la maladie chronique à la qualité de vie. Méthodes d'évaluation. Rev Mal Respir. 2003;20:S34-S37.
67. Edmonds ZV, Mower WR, Lovato LM, Lomeli R. The reliability of vital sign measurements. Ann Emerg Med. 2002;39(3):233-237.
68. Blizzard L, Grimmer KA, Dwyer T. Validity of a measure of the frequency of headaches with overt neck involvement, and reliability of measurement of cervical spine anthropometric and muscle performance factors. Arch Phys Med Rehabil. 2000;81(9):1204-1210.
69. Langendijk HA, Lamers RJS, ten Velde GPM, et al. Is the chest radiograph a reliable tool in the assessment of tumor response after radiotherapy in nonsmall cell lung carcinoma? Int J Radiat Oncol Biol Phys. 1998;41(5):1037-1045.
70. Moertel CG, Hanley JA. The effect of measuring error on the results of therapeutic trials in advanced cancer. Cancer. 1976;38(1):388-394.
71. Warde P, Rideout DF, Herman S, et al. Computed tomography in advanced ovarian cancer: inter- and intraobserver reliability. Invest Radiol. 1986;21(1):31-33.
72. Warr D, McKinney S, Tannock I. Influence of measurement error on assessment of response to anticancer chemotherapy: proposal for new criteria of tumor response. J Clin Oncol. 1984;2(9):1040-1046.
73. Erasmus JJ, Gladish GW, Broemeling L, et al. Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response. J Clin Oncol. 2003;21(13):2574-2582.
74. Martin S, Jensen R, Daly L, Jergenson C, Johnson MB, Buell T. Comparison of two methods of bedside blood glucose screening in the NICU: evaluation of accuracy and reliability. Neonatal Netw. 1997;16(2):39-43.
75. Earles DR, Morris HH, Peng CYJ, Koceja DM. Assessment of motoneuron excitability using recurrent inhibition and paired reflex depression protocols: a test of reliability. Electromyogr Clin Neurophysiol. 2002;42(3): 159-166.
76. Gerin W, Christenfeld N, Pieper C, et al. The generalizability of cardiovascular responses across settings. J Psychosom Res. 1998;44(2):209-218.
77. Faul JL, Demers EA, Burke CM, Poulter LW. The reproducibility of repeat measures of airway inflammation in stable atopic asthma. Am J Respir Crit Care Med. 1999;160(5, pt 1):1457-1461.
78. McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res. 1995;4(4):293-307.
79. Wiklund I, Comerford MB, Dimenas E. The relationship between exercise tolerance and quality of life in angina pectoris. Clin Cardiol. 1991;14(3):204-208.
80. Reuben DB, Valle LA, Hays RD, Siu AL. Measuring physical function in community-dwelling older persons: a comparison of self-administered, interviewer-administered, and performance-based measures. J Am Geriatr Soc. 1995;43(1):17-23.
81. Yohannes AM, Roomi J, Waters K, Connolly MJ. Quality of life in elderly patients with COPD: measurement and predictive factors. Respir Med. 1998;92(10):1231-1236.
82. Shingo S, Zhang J, Reiss TF. Correlation of airway obstruction and patient-reported endpoints in clinical studies. Eur Respir J. 2001;17(2):220-224.
83. Leidy NK, Schmier JK, Jones MK, Lloyd J, Rocchiccioli K. Evaluating symptoms in chronic obstructive pulmonary disease: validation of the Breathlessness, Cough and Sputum Scale. Respir Med. 2003;97(suppl A):S59-S70.
84. Cella D. The effects of anemia and anemia treatment on the quality of life of people with cancer. Oncology (Williston Park). 2002;16(9, suppl 10):125-132.
85. Cella D, Dobrez D, Glaspy J. Control of cancer-related anemia with erythropoietic agents: a review of evidence for improved quality of life and clinical outcomes. Ann Oncol. 2003;14(4):511-519.
86. Muller-Buhl U, Kirchberger I, Wiesemann A. Relevance of claudication pain distance in patients with peripheral arterial occlusive disease. Vasa. 1999;28(1):25-29.
87. Muller-Buhl U, Engeser P, Klimm HD, Weisemann A. Quality of life and objective disease criteria in patients with intermittent claudication in general practice. Fam Pract. 2003;20(1):36-40.
88. Hannan MT, Felson DT, Pincus T. Analysis of the discordance between radiographic changes and knee pain in osteoarthritis of the knee. J Rheumatol. 2000;27(6):1513-1517.
89. Kwoh CK, Ibrahim SA. Rheumatology patient and physician concordance with respect to important health and symptom status outcomes. Arthritis Rheum. 2001;45(4):372-377.
90. Edwards SGM, Playford ED, Hobart JC, Thompson AJ. Comparison of physician outcome measures and patients' perception of benefits of inpatient neurorehabilitation. BMJ. 2002;324(7352):1493.
91. Campbell R, Quilty B, Dieppe P. Discrepancies between patients' assessments of outcome: qualitative study nested within a randomised controlled trial. BMJ. 2003;326(7383):252-253.
92. Langendijk H, Aaronson NK, de Jong JM, ten Velde GP, Muller MJ, Wouters M. The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol. 2000;55(1):19-25.
93. Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR. Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer. 2001;31(2-3):233-240.
94. Shadbolt B, Barresi J, Craft P. Self-rated health as a predictor of survival among patients with advanced cancer. J Clin Oncol. 2002;20(10):2514-2519.
95. Maisey NR, Norman A, Watson M, Allen MJ, Hill ME, Cunningham D. Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer. 2002;38(10):1351-1357.
96. Lakusta CM, Atkinson MJ, Robinson JW, Nation J, Taenzer PA, Campo MG. Quality of life in ovarian cancer patients receiving chemotherapy. Gynecol Oncol. 2001;81(3):490-495.
97. Herndon JE II, Fleishman S, Kornblith AB, Kosty M, Green MR, Holland J. Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? Cancer. 1999;85(2):333-340.
98. Konstam V, Salem D, Pouleur H, et al, SOLVD Investigators. Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. Am J Cardiol. 1996;78(8):890-985.
99. Fan VS, Curtis JR, Tu SP, McDonell MB, Fihn SD, Ambulatory Care Quality Improvement Project Investigators. Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases. Chest. 2002;122(2):429-436.
100. Wolfe F, Michaud K, Gefeller O, Choi HK. Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum. 2003;48(6):1530-1542.
101. Eton D, Fairclough D, Cella D, Yount SE, Bonomi P, Johnson DH. Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: results from Eastern Cooperative Oncology Group Study 5592. J Clin Oncol. 2003; 21(8):1536-1543.
102. Brown JE, Butow PN, Culjak G, Coates AS, Dunn SM. Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanoma. Br J Cancer. 2000;83(11):1448-1453.
103. Butow PN, Coates AS, Dunn SM. Psychosocial predictors of survival: metastatic breast cancer. Ann Oncol. 2000;11(4):469-474.
104. Chassany O, Marquis P, Scherrer B, et al. Validation of a specific quality of life questionnaire in functional digestive disorders. Gut. 1999; 44(4):527-533.
105. Mor V, Guadagnoli E. Quality of life measurement: a psychometric tower of Babel. J Clin Epidemiol. 1988;41(11):1055-1058.
106. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research. Guidance for industry: clinical trial endpoints for the approval of cancer drugs and biologics. May 2007. Available at: www.fda.gov/cder/guidance/ 7478fnl.pdf. Accessed September 10, 2007.
107. Flikkila T, Nikkola-Sihto A, Kaarela O, Paakko E, Raatikainen T. Poor interobserver reliability of AO classification of fractures of the distal radius: additional computed tomography is of minor value. J Bone Joint Surg Br. 1998;80(4):670-672.
108. Sjoden GO, Movin T, Guntner P, et al. Poor reproducibility of classification of proximal humeral fractures: additional CT of minor value. Acta Orthop Scand. 1997;68(3):239-242.
109. Sahlroot JT, Pledger GW. Dosage adjustments in response to monitored plasma concentrations: can unblinded staff adhere to objective criteria? J Biopharm Stat. 1994;4(1):91-100.
110. Grech ED, Ramsdale DR. Acute coronary syndrome: unstable angina and non-ST segment elevation myocardial infarction. BMJ. 2003;326(7401):1259- 1261.
111. Wang JK, Nauss LA, Thomas JE. Pain relief by intrathecally applied morphine in man. Anesthesiology. 1979;50(2):149-151.
112. Behar M, Magora F, Olshwang D, Davidson JT. Epidural morphine in treatment of pain. Lancet. 1979;1(8115):527-529.
113. Smith TJ, Staats PS, Deer T, et al, Implantable Drug Delivery Systems Study Group. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2002; 20(19):4040-4049.
114. GlaxoSmithKline. Prescribing information, Advair Diskus.® Available at: http://www.fda.gov/cder/foi/label/2006/021077s028lbl.pdf. Accessed August 8, 2007.
115. Justice AC, Holmes W, Gifford AL, et al, Adult AIDS Clinical Trials Unit Outcomes Committee. Development and validation of a self-completed HIV symptom index. J Clin Epidemiol. 2001;(suppl 1):S77-S90.
116. Justice AC, Rabeneck L, Hays RD, Wu AW, Bozzette SA, Outcomes Committee of the AIDS Clinical Trials Group. Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: a comparison with self-reported symptoms. J Acquir Immune Defic Syndr. 1999;21(2):126-133.
117. Komiti A, Judd F, Grech P, et al. Depression in people living with HIV/AIDS attending primary care and outpatient clinics. Aust N Z J Psychiatry. 2003;37(1):70-77.
118. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ III. Self-reported diarrhea: what does it mean? Am J Gastroenterol. 1994;89(8):1160-1164.
119. Irvine EJ, Ferrazzi S, Pare P, Thompson WG, Rance L. Health-related quality of life in functional GI disorders: focus on constipation and resource utilization. Am J Gastroenterol. 2002;97(8):1986-1993.
120. Mertz H, Beck K, Dixon W, Esquivel MA, Hays RD, Shapiro MF. Validation of a new measure of diarrhea. Dig Dis Sci. 1995;40(9):1873-1882.
121. Dwyer KA, Coty MB, Smith CA, Dulemba S, Wallston KA. A comparison of two methods of assessing disease activity in the joints. Nurs Res. 2001;50(4):214-221.
122. Pincus T, Strand V, Koch G, et al. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial. Arthritis Rheum. 2003;48(3):625-630.